Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
about
Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionNeuroendocrine differentiation in prostate cancerElevated matrix metalloproteinase-9 in patients with systemic sclerosisCharacterization of the interaction between protein 4.1R and ZO-2. A possible link between the tight junction and the actin cytoskeletonAngiogenesis and prostate cancer tumor growth.Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cellsTransforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signalingUrokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.Endoglin suppresses human prostate cancer metastasis.A glimpse of matrix metalloproteinases in diabetic nephropathy.TGF-β and restenosis revisited: a Smad link.Integrin α3β1 signaling through MEK/ERK determines alternative polyadenylation of the MMP-9 mRNA transcript in immortalized mouse keratinocytesIntegrin α3β1 as a breast cancer targetDual role of SnoN in mammalian tumorigenesisThe multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9.BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding proteinThe role of transforming growth factor beta signaling in messenger RNA stability.The bone morphogenetic protein 1/Tolloid-like metalloproteinasesMechanobiology of TGFβ signaling in the skeleton.Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.Macrophage secretome from women with HIV-associated neurocognitive disorders.Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammationAn immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasionTargeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression.CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway.Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1).Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.Activity of matrix metallo proteinases (MMPs) and the tissue inhibitor of MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells.The effect of TGF-beta2 on MMP-2 production and activity in highly metastatic human bladder carcinoma cell line 5637.Molecular mechanisms of nitric oxide-dependent inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) in MCF-7 cells.Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression.Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.
P2860
Q24568374-8D3B751F-77E3-4F87-BDEB-D72D810F39D2Q24657547-9FB7EAF5-3F67-430D-B613-851A43D263A3Q24798908-23660737-E7CF-47CB-867D-191BBF31226EQ28139599-5B325CAF-7635-43B4-905A-98EC113A4008Q30312026-E92D1FD8-B73A-4079-BA76-DB9C89DE8780Q33405455-A8FD94FC-6498-4A5A-87AF-2920A8E43395Q33865456-3EA37EB3-9963-4E70-AD4D-F69B04D75E5BQ33923957-3103E4D4-11A8-414B-A1D5-9F81F2B54DDFQ33943172-F51606E5-F33C-44C6-AE21-3A7E84986E1DQ34012586-C39D9296-B11D-4100-87B5-D4A729B3EC84Q34489359-DA14ADD7-0D20-4DFB-9A94-ECE1750BA3A5Q34614196-A9656385-0849-4628-9A52-F27ADD04EA00Q34796034-E88B4B19-7C6B-4017-A640-BD0505D10A5BQ34798852-88DC6EEA-40C9-427F-AE36-05F3C91871D7Q35159426-B8D0D7BD-E752-44EC-9AC5-687287292C3EQ35539262-A6A2EA16-56C2-45E0-84D4-05C136F3A2A9Q35641680-E6EB689F-B2D3-44A6-A87B-CF92B4C308B3Q35994104-D7D618FE-D997-415A-9158-1108A45D94E6Q36118959-55D0F546-84B4-41AD-9198-BEB8A9FCE0B7Q36360686-830EAA98-21BA-4B86-8FDE-09146AA9E6F2Q36846125-7DCFFE6E-E6CB-4D5E-A829-D5CBCE75C555Q36923713-D8B13D7D-B66F-42A8-B41D-FCB0AA875DA1Q37118844-9BD6DEC8-F1F2-40F1-B7C8-2D9075A8F8FCQ37194373-CAE31771-BF64-4102-A829-A13587239725Q37258851-EAA8A4E8-0B44-4E1E-8A77-64644190E6A9Q37287836-7F8015DA-C172-4BD1-8838-8AD94517629DQ37436249-B4C1DDB3-4183-48CD-8CB1-8DDCA4583AE1Q37924999-B1B2CE0A-4A9B-4A2E-A528-FDD7FBE6ED8DQ38261626-A518B28D-7D79-47E2-B7BD-1FFD0FC48F62Q38923285-17BE23C6-FD7B-4DA1-993A-C660D1F7BBAEQ39012101-9906D461-F8D1-4E19-A37A-5218B0E88819Q39150831-BBB53387-1856-4F27-BB42-F98E6DF0AED0Q39166800-9D676A3E-D23A-45B3-B247-731A4FEBFBE1Q39328629-FDCC846B-2FC9-438E-982D-C37FF076938AQ39472000-B3A863E9-027E-4160-96FB-DEF777E2EAD9Q39883545-CFA3CCCC-6D6E-44AE-9871-A4D40DE7AE7BQ39897690-E2F34503-B702-4332-902C-736EDC32D2F5Q40029092-42926CB8-227B-4A2A-A09F-2D6F785D0A32Q40256618-50F7AB65-BDCD-46BB-89D8-0924AA5C07C9Q40375490-A4C0D82B-D5C7-4E54-B205-F71C3378C1F2
P2860
Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Novel regulation of type IV co ...... an prostate cancer cell lines.
@en
type
label
Novel regulation of type IV co ...... an prostate cancer cell lines.
@en
prefLabel
Novel regulation of type IV co ...... an prostate cancer cell lines.
@en
P2860
P356
P1476
Novel regulation of type IV co ...... an prostate cancer cell lines.
@en
P2093
T C Thompson
P2860
P304
P356
10.1091/MBC.10.2.407
P577
1999-02-01T00:00:00Z